✦ LIBER ✦

Cost Effectiveness of Darunavir/ritonavir Combination Antiretroviral Therapy for Treatment-Naive Adults with HIV-1 Infection in Canada

✍ Scribed by Brogan, Anita J.; Smets, Erik; Mauskopf, Josephine A.; Manuel, Sarah A. L.; Adriaenssen, Ines

Book ID: 125387026
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 569 KB
Volume: 32
Category: Article
ISSN: 1170-7690
DOI: 10.1007/s40273-014-0173-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ritonavir-boosted darunavir combined wit

Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

✍ Raffi, François; Babiker, Abdel G; Richert, Laura; Molina, Jean-Michel; George, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 395 KB

Abacavir versus Zidovudine Combined with

Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults

✍ DeJesus, Edwin; Herrera, Gisela; Teofilo, Eugenio; Gerstoft, Jan; Buendia, Carlo 📂 Article 📅 2004 🏛 University of Chicago Press 🌐 English ⚖ 110 KB

PIN65 Cost-Effectiveness of First-Line A

PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia: An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients

✍ J. Moller; K. Desai; K.N. Simpson; R. Baran; B. Dietz; O. Van de Steen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Comparison of Body Composition Changes B

Comparison of Body Composition Changes Between Atazanavir/Ritonavir and Lopinavir/Ritonavir Each in Combination with Tenofovir/Emtricitabine in Antiretroviral-Naïve Patients with HIV-1 Infection

✍ Moyle, Graeme J.; Hardy, Hélène; Farajallah, Awny; DeGrosky, Michelle; McGrath, 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 371 KB

Once-daily dolutegravir versus darunavir

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

✍ Clotet, Bonaventura; Feinberg, Judith; van Lunzen, Jan; Khuong-Josses, Marie-Aud 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 328 KB

Cost-effectiveness analysis of emtricita

Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients

✍ Rainel Sánchez-de la Rosa; Luis Herrera; Santiago Moreno 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 704 KB